DE60318558D1 - Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen - Google Patents

Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen

Info

Publication number
DE60318558D1
DE60318558D1 DE60318558T DE60318558T DE60318558D1 DE 60318558 D1 DE60318558 D1 DE 60318558D1 DE 60318558 T DE60318558 T DE 60318558T DE 60318558 T DE60318558 T DE 60318558T DE 60318558 D1 DE60318558 D1 DE 60318558D1
Authority
DE
Germany
Prior art keywords
treatment
prophylaxis
lactobacillus farciminis
digestive diseases
farciminis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60318558T
Other languages
English (en)
Other versions
DE60318558T2 (de
Inventor
Jean Fioramonti
Lionel Bueno
Vassilia Theodorou
Florence Lamine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Publication of DE60318558D1 publication Critical patent/DE60318558D1/de
Application granted granted Critical
Publication of DE60318558T2 publication Critical patent/DE60318558T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE60318558T 2002-03-28 2003-03-21 Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen Expired - Lifetime DE60318558T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0203891A FR2837711B1 (fr) 2002-03-28 2002-03-28 Utilisation de la lactobacillus farciminis pour la prevention ou le traitement de pathologies digestives
FR0203891 2002-03-28
PCT/FR2003/000903 WO2003082307A1 (fr) 2002-03-28 2003-03-21 Utilisation de lactobacillus farciminis pour la prevention ou le traitement de pathologies digestives.

Publications (2)

Publication Number Publication Date
DE60318558D1 true DE60318558D1 (de) 2008-02-21
DE60318558T2 DE60318558T2 (de) 2009-01-22

Family

ID=27839273

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318558T Expired - Lifetime DE60318558T2 (de) 2002-03-28 2003-03-21 Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen

Country Status (10)

Country Link
US (2) US7294337B2 (de)
EP (1) EP1487466B1 (de)
AT (1) ATE383163T1 (de)
AU (1) AU2003227852A1 (de)
CA (1) CA2480387C (de)
DE (1) DE60318558T2 (de)
DK (1) DK1487466T3 (de)
ES (1) ES2299698T3 (de)
FR (1) FR2837711B1 (de)
WO (1) WO2003082307A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101247853B (zh) 2005-04-13 2014-11-12 轴突公司 具有nos抑制活性的取代的吲哚化合物
AR060451A1 (es) * 2006-04-13 2008-06-18 Neuraxon Inc Compuestos de indol 1,5 y 3,6-sustituidos con actividad inhibitoria de nos
FR2922450B1 (fr) * 2007-10-19 2014-06-13 Lallemand Sas Utilisation de bacteries lactique pour la prevention et/ou le traitement de pathologies cutanees
AU2008321353A1 (en) * 2007-11-16 2009-05-22 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for treating visceral pain
CA2705833A1 (en) * 2007-11-16 2009-05-22 Subhash C. Annedi 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
NZ586082A (en) * 2007-11-16 2013-03-28 Neuraxon Inc Indole compounds and methods for treating visceral pain
WO2009154463A2 (en) * 2008-06-20 2009-12-23 Stichting Top Institute Food And Nutrition Butyrate as a medicament to improve visceral perception in humans
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
US20130017174A1 (en) * 2011-07-12 2013-01-17 The Board Of Trustees Of The University Of Arkansas Compositions and methods for increasing health and reducing pathogenic bacteria in animals
US20220008489A1 (en) * 2018-09-26 2022-01-13 Meiji Co., Ltd. Agent for improving mitochondrial function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764802A1 (fr) * 1996-12-24 1998-12-24 Standa Lab Sa Composition adsorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal
AU2296897A (en) * 1997-03-20 1998-10-20 Jean James Garreau Food products based on soybean milk and method for making same
FR2785809B1 (fr) * 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1344458A1 (de) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. System zur Verabreichung von Probiotika

Also Published As

Publication number Publication date
US7628991B2 (en) 2009-12-08
AU2003227852A1 (en) 2003-10-13
ES2299698T3 (es) 2008-06-01
CA2480387A1 (fr) 2003-10-09
WO2003082307A1 (fr) 2003-10-09
DE60318558T2 (de) 2009-01-22
US20080085268A1 (en) 2008-04-10
FR2837711A1 (fr) 2003-10-03
US7294337B2 (en) 2007-11-13
ATE383163T1 (de) 2008-01-15
FR2837711B1 (fr) 2005-05-06
EP1487466B1 (de) 2008-01-09
CA2480387C (fr) 2013-04-23
DK1487466T3 (da) 2008-05-19
EP1487466A1 (de) 2004-12-22
US20050244389A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
MX2020008271A (es) Inhibidor de fap.
DE60129823D1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
ATE440132T1 (de) Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger
NO20050210L (no) Antibakterielle amid-makrocykluser
ATE412414T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen
ATE456955T1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
ATE383163T1 (de) Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen
TW200716162A (en) Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
EA200801310A1 (ru) Фармацевтические препараты и их применение при лечении половой дисфункции у женщин
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
PH12020551905A1 (en) C-mannoside compounds useful for the treatment of urinary tract infections
DE502005008925D1 (de) Substituierte nonadepsipeptide
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
RS57471B1 (sr) Nova probiotička starter kultura za humanu i animalnu primenu
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
TNSN06147A1 (en) Use of cathepsin k inhibitors for treating of severe bone loss diseases
MX2021011183A (es) Fitoecdisonas y los derivados de las mismas para su uso en el tratamiento de la alteracion de la funcion respiratoria.
ATE308895T1 (de) Behandlung von infektionen in tieren
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
EP4253568A3 (de) Orale antimikrobielle oder antiseptische spülung zur verwendung bei der behandlung oder vorbeugung des barrett-ösophagus
RU2009105954A (ru) Способ индукции интерферона для профилактики и лечения вирусных болезней животных

Legal Events

Date Code Title Description
8364 No opposition during term of opposition